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Banff criteria to a morphometric approach.
Background. Donor glomerulosclerosis, interstitial fibrosis,
and fibrous intimal thickening correlate with graft outcome. We
evaluate chronic lesions in donor biopsies according to Banff
criteria and with a morphometric technique to ascertain their
predictive value on graft outcome.
Methods. We evaluated 77 cadaveric donor biopsies accord-
ing to Banff criteria. Glomerulosclerosis was expressed as the
percentage of global sclerotic glomeruli. The following mor-
phometric parameters were obtained: cortical interstitial vol-
ume fraction (Vvint/c), cortical glomerular volume fraction
(Vvglom/c), mean glomerular volume (Vg), mean and maxi-
mal intimal arterial volume fraction (Vvintima/art), and Vvin-
tima/art of the largest artery. We evaluated the correlation
of histologic lesions with delayed graft function, 3 months’
glomerular filtration rate (GFR), and death-censored graft sur-
vival.
Results. Multivariate logistic regression showed that delayed
graft function was associated with cv score [relative risk (RR)
4.2 and 95% CI 1.1 to 16.0) and glomerulosclerosis (RR 1.06
and 95% CI 1.01 to 1.13). Stepwise regression showed that
Vvint/c and glomerulosclerosis were independent predictors of
3 months’ GFR (R = 0.62, P = 0.0001). Repeated analysis not
considering morphometric parameters showed that glomeru-
losclerosis, cv score and ci score were independent predictors
of 3 months’ GFR (R = 0.64, P = 0.0001). A donor chronic
damage score was generated considering glomerulosclerosis, cv
score and ci score. This score after adjusting for clinical variables
was associated with 3 months’ GFR (R = 0.71, P < 0.0001) and
death-censored graft survival (RR 2.2 and 95% CI 1.3 to 3.7).
Conclusion. Combined evaluation of donor glomerulosclero-
sis, chronic vascular and interstitial damage according to Banff
criteria allows a precise prediction of graft outcome. Morpho-
metric evaluation of donor biopsies does not improve the pre-
dictive value of semiquantitative grading.
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Age-dependent lesions evaluated in preimplantation
biopsies are associated with renal allograft outcome.
In the last decade, donor age and the proportion of
donors with preexisting diabetes and/or hypertension has
steadily increased [1, 2]. Furthermore, dual kidney trans-
plant programs have started to employ marginal kidneys
in order to expand the organ pool available for renal
transplantation [3–5]. Thus, it has been proposed that
preimplantation biopsies may be an important tool in
donor selection and prediction of recipient outcome [6].
Chronic allograft damage assessed with a semiquan-
titative or a morphometric approach on preimplanta-
tion biopsies correlates with the incidence of delayed
graft function, short- and long-term renal function and
allograft survival. The following histopathologic lesions
evaluated with a semiquantitative scale are associated
with graft outcome: chronic tubulointerstitial damage
[7], arteriolar hyaline changes [8, 9], and fibrous intimal
thickening [8]. Moreover, the percentage of global scle-
rotic glomeruli [9, 10], as well as morphometric evalu-
ation of cortical interstitial volume fraction [11], base-
line glomerular size [12], and fibrous intimal thickening
[13] in preimplantation biopsies also correlates with al-
lograft outcome. However, it is not clear which of these
lesions evaluated either with a semiquantitative or quan-
titative technique allows the best prediction on outcome
and it has not been determined whether the estimation of
chronic damage in all renal compartments allows a bet-
ter prediction of outcome than the evaluation of chronic
lesions in a single renal compartment.
The aim of this study is to evaluate which lesions in
preimplantation biopsies assessed either by means of
Banff criteria or a morphometric technique are associ-
ated with graft outcome adjusting for clinical variables.
METHODS
Patients transplanted in our center between June 2000
and December 2001, in whom a preimplantation biopsy
1595
1596 Lopes et al: Evaluation of preimplantation kidney biopsies
with at least 10 glomeruli and one arterial section was
available, were included in the present study.
Biopsies
Wedge donor biopsies were obtained from all kidneys
harvested at our center before implantation and pro-
cessed for routine light microscopy. Tissue was embed-
ded in paraffin, cut in 4 lm thick sections and stained
with hematoxylin and eosin, periodic acid-Schiff (PAS),
Masson’s trichrome, and silver methenamine. Biopsies
were evaluated according to Banff criteria [14] and with a
morphometric technique by a single observer (M.C. and
J.A.L., respectively). Glomerulosclerosis was evaluated
and expressed as the percentual value of global sclerotic
glomeruli.
Morphometry
Masson’s trichrome–stained sections were employed
for histomorphometric analysis. Mean glomerular vol-
ume (Vg) was estimated by a point counting method in
all glomeruli available in one section. For this purpose, a
grid of 560 points was displayed on a television screen and
the distance between grid points was calibrated with a mi-
crometer ruler. Glomerulus was defined as the area inside
the minimal convex polygon described by the outer cap-
illary loops of the tuft. The total number of points hitting
the glomerular tuft were counted at 200× magnification.
Mean glomerular volume was estimated from the mean
glomerular area (A) according to the Weibel and Gomez
method as [15]:
Vg = A3/2 ∗ b/d (equation 1)
where b is 1.38, the shape coefficient of the sphere, and d
is 1.01, the size distribution of glomeruli assuming a 10%
coefficient of variation of the caliber diameter.
Cortical interstitial volume fraction (Vvint/c) was esti-
mated by means of a point counting technique at 100×
magnification using all the available cortical tissue. A
graticule of 560 points (35 coarse and 525 fine points)
was added to each field displayed on a television screen
and the number of fine points hitting the space of interest
(P1) and the number of coarse points hitting the refer-
ence space (P2) were counted. The volume fraction was
estimated according to:
Vv = (P1)/(P2 ∗ 16) ∗ 100 (equation 2)
Interstitial space was defined as the area between tubu-
lar membranes. Points intersecting tubular basal mem-
brane were considered tubular points.
Intimal arterial volume fraction (Vvintima/art) was
also estimated by means of a point counting technique
at 400× magnification using the same graticule. An arte-
rial section was defined as the space inside the adventitia.
The intima was defined as the space lying between the
inner elastica and the lumen. In arteries showing redupli-
cation of the inner elastica, the intima was considered the
vascular space inside the outer layer of the inner elastica.
Only arterial sections with at least two muscular layers
were considered.
Taking into consideration that Banff criteria evaluate
cv score in the artery with maximal intimal thickening,
we considered in each biopsy the following parameters:
(1) mean Vvintima/art, (2) maximal Vvintima/art, and (3)
Vvintima/art of the largest artery.
Clinical variables
The following variables were evaluated in each patient
at the time of surgery: age and gender of the donor and
the recipient, last panel reactive antibodies, etiology of
end-stage renal disease (ESRD), number of transplants,
number of human leukocyte antigen (HLA) mismatches
and cold ischemia time. After surgery, the presence of de-
layed graft function and acute rejection were evaluated.
Two outcome variables were considered: 3 months’
glomerular filtration rate (GFR) and death-censored
graft survival. GFR was estimated according to the
Cockroft-Gault formula [16]. In patients who lost their
graft before the third month, GFR was arbitrarily consid-
ered to be 10 mL/min/1.73 m2. Patients who died before
the third month were not considered for this analysis.
Statistics
Results are expressed as the mean ± standard devi-
ation. Comparison between groups was performed by
means of Mann-Whitney U test for ordinal data and
with Student t test or analysis of variance (Scheffe´ test
for individual comparisons) for quantitative data. Spear-
man correlation coefficient (rho) was employed to study
the relationship between ordinal or nonnormally dis-
tributed quantitative data. Simple regression analysis was
employed to study the relationship between normally
distributed quantitative variables and 3 months’ GFR.
Logistic regression analysis was used to study indepen-
dent predictors of posttransplant delayed graft function.
Forward stepwise multiple regression analysis was em-
ployed to analyze independent predictors of 3 months’
GFR. Graft survival was calculated by the Kaplan-Meier
method and comparison between groups was done by the
log rank test. Univariate and multivariate Cox regression
analysis was done to analyze histologic and clinical vari-
ables associated with graft survival.
A two-tailed P value < 0.05 was considered significant.
RESULTS
Patients
During the study period, 114 patients received a sin-
gle cadaveric renal transplant and a donor biopsy was
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Table 1. Demographic characteristics of patients
Mean ± standard
Variable deviation Range
Donor age years 45 ± 16 18–77
Donor gender male/female 51/26
Recipient age years 51 ± 12 23–71
Recipient gender male/female 51/26
Human leukocyte antigen mismatches 3.3 ± 1.1 1–6
Panel reactive antibodies% 6.4 ± 16.4 0–96
Cold ischemia time hours 20 ± 4 11–32
First transplant/retransplantation 69/8
Etiology of renal failure
Glomerulonephritis 21
Interstitial nephritis 21
Autosomal-dominant polycystic 18
kidney disease
Nephroangiosclerosis 3
Unknown 24
Delayed graft function no/yes 54/23
Acute rejection no/yes 62/15
performed in the 89 kidneys procured at our center. For
the present study, 77 patients with at least 10 glomeruli
and one arterial section were included. The biopsy con-
tained at least two arterial sections in 66 cases and
one section in 11 patients. Demographic characteris-
tics of patients are summarized in Table 1. During this
period, different combinations of immunosuppressive
drugs were employed. Thirty-nine patients received a
cyclosporine and prednisone based immunosuppression.
This treatment was associated with antilymphocytic in-
duction therapy (N = 10), mycophenolate mofetil (N =
38), or sirolimus (N = 1). Thirty-one patients received
a tacrolimus and prednisone based immunosuppression
associated with mycophenolate mofetil (N = 28), or
sirolimus (N = 3). Seven patients received a calcineurin-
free immunosuppression.
Mean follow-up was 27 ± 13 months. Fourteen patients
lost their graft due to the following reasons: never func-
tioning kidney (N = 2), vascular thrombosis (N = 1),
acute rejection (N = 1), urinary fistula (N = 1), nontreat-
ment compliance (N = 1), chronic allograft nephropathy
(N = 3), glomerulonephritis associated with hepatitis C
virus (N = 1), and four patients died before the third
month due to cardiac arrest (N = 2), urinary sepsis (N =
1), and pulmonary hemorrhage (N = 1).
Biopsies
Mean number of glomeruli, mean number of arte-
rial sections, percentage of glomerulosclerosis, chronic
Banff scores, and the results of the morphometric anal-
ysis are shown in Table 2. According to Banff criteria,
donor biopsies were classified as normal in 57 (74.1%)
cases and chronic renal lesions indistinguishible from
chronic allograft nephrology in 20 (25.9%) cases. Patients
with chronic allograft nephrology were graded as follows:
chronic allograft nephrology grade I(a) (N = 10), chronic
Table 2. Histologic Banff scores and morphometric parameters in
the studied set of biopsies.
Mean ± standard
Variable deviation Range
Number of glomeruli 26 ± 16 10–103
Number of arterial sections 3.8 ± 2.9 1–9
Percentage of glomerulosclerosis 5.5 ± 8.8 0–46
cg score 0
ci score 0.45 ± 0.68 0–2
ct score 0.45 ± 0.62 0–2
cv score 0.13 ± 0.41 0–2
ah score 0.13 ± 0.47 0–3
Vvint/c % 7.2 ± 5.0 1.5–28.5
Vvglom/c % 6.1 ± 1.9 1.8–10.1
Vg ×106 l3 5.2 ± 2.1 2.0–12.8
Mean Vvintima/art % 12.4 ± 4.4 6.4–31.5
Maximal Vvintima/art % 17.2 ± 9.8 6.5–69.7
Vvintima/art of the largest artery % 13.1 ± 9.1 1.3–69.7
Abbreviations are: Vvint/c, cortical interstitial volume fraction; Vvglom/c,
cortical glomerular volume fraction; Vg, mean glomerular volume; Vvintima/art,
intimal arterial volume fraction.
allograft nephrology grade I(b) (N = 5), chronic allograft
nephrology grade II(a) (N = 4), and chronic allograft
nephrology grade II(b) (N = 1).
Relationship between Banff scores and morphometric
analysis
Banff ci score correlated with Vvint/c (rho = 0.68,
P = 0.0001). The correlation between cv score and the
different morphometric measurements of intimal arterial
thickening was rho = 0.26, P = 0.021 for maximal Vvin-
tima/art; rho = 0.26, P = 0.026 for mean Vvintima/art;
and rho = 0.23, P = 0.043 for Vvintima/art of the largest
artery.
Relationship between donor characteristics and
histologic lesions
Donor age correlated with ci score (rho = 0.54, P =
0.0001), ct score (rho = 0.53, P = 0.0001), and cv score
(rho = 0.42, P = 0.002), but not with cg and ah scores.
Donor age was also associated with Vvint/c (R = 0.64,
P = 0.0001), Vg (R = 0.55, P = 0.0001), mean Vvin-
tima/art (R = 0.32, P = 0.0043), maximal Vvintima/art
(R = 0.37, P = 0.0007), and Vvintima/art of the largest
artery (R = 0.37, P = 0.0008).
Donor gender was not associated with any histologic
parameter.
Relationship between histologic lesions, donor clinical
data, and delayed graft function
The following variables were associated with post-
transplant delayed graft function: percentage of glomeru-
losclerosis, cv score, and maximal Vvintima/art (Table 3).
Logistic regression analysis showed that only two his-
tologic variables were independent predictors of delayed
graft function: cv score [relative risk (RR) 4.2 and 95%
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Table 3. Relationship between histologic lesions and delayed graft
function
Variable No (N = 54) Yes (N = 23) P value
Glomerulosclerosis % 4 ± 6 9 ± 13 0.024
cg score 0 0 ns
ci score 0.37 ± 0.62 0.65 ± 0.77 ns
ct score 0.39 ± 0.63 0.61 ± 0.58 ns
cv score 0.06 ± 0.23 0.30 ± 0.63 0.013
ah score 0.11 ± 0.37 0.17 ± 0.65 ns
Vvint/c % 6.6 ± 4.5 8.5 ± 6.0 ns
Vvglom/c % 6.0 ± 2.0 6.2 ± 1.8 ns
Vg ×106 l3 4.9 ± 2.1 5.9 ± 1.9 ns
Mean Vvintima/art % 11.8 ± 4.2 13.8 ± 4.6 ns
Maximal Vvintima/art % 15.6 ± 8.4 20.5 ± 12.2 0.047
Vvintima/art of the 11.9 ± 6.4 16.2 ± 13.1 ns
largest artery %
Abbreviations are: Vvint/c, cortical interstitial volume fraction; Vvglom/c,
cortical glomerular volume fraction; Vg, mean glomerular volume; Vvintima/art,
intimal arterial volume fraction.
CI 1.1 to 16.0] and percentage of glomerulosclerosis (RR
1.06 and 95% CI 1.01 to 1.13). However, when donor clin-
ical variables were also considered, only donor age was
an independent predictor of delayed graft function (RR
1.04 and 95% CI 1.01 to 1.09) (P = 0.043).
Relationship between histologic lesions and graft
outcome
Four out of the 77 patients died before the third month
and were not considered for this analysis. Three out of
the remaining 73 patients lost their graft before the third
month and an arbitrary GFR of 10 mL/min/1.73 m2 was
considered.
There was a correlation between 3 months’ GFR and
the following histologic variables: ci score (rho = −0.41,
P = 0.0005), ct score (rho = −0.38, P = 0.0014), cv score
(rho = −0.48, P = 0.0001), percentage of glomeruloscle-
rosis (R = −0.52, P = 0.0001), Vvint/c (R = −0.57, P =
0.0001), Vg (R = −0.30, P = 0.0102), mean Vvintima/art
(R = −0.26, P = 0.0250), maximal Vvintima/art (R =
−0.25, P = 0.0296) and Vvintima/art of the largest artery
(R = −0.30, P = 0.0111).
In a first approach, forward stepwise regression analy-
sis considering significant variables in the univariate anal-
ysis, showed that Vvint/c and percentage of glomeru-
losclerosis were the only independent predictors of
3 months’ GFR (R = 0.62, P = 0.0001). In order to
evaluate whether morphometry offered any advantage
over semiquantitative grading, this analysis was repeated
not considering morphometric parameters. The following
predictors of 3 months’ GFR were entered into the statis-
tical model in the following order: percentage of glomeru-
losclerosis, cv score, and ci score (R = 0.64, P = 0.0001).
In order to simplify the evaluation of donor biop-
sies, the best cutoff for percentage of glomeruloscle-
rosis was determined. To transform glomerulosclerosis
into a dicotomous variable the following thresholds were
Table 4. Relationship between donor chronic damage score, 3
months’ glomerular filtration rate (GFR) (expressed as mL/min/1.73
m2) and death-censored graft survival (%)
Score 0 1 2 ≥3 P value
Number 40 19 9 5
3 months’ GFR 69 ± 18 56 ± 18a 37 ± 16a,b 22 ± 16a,b 0.0001
Survival 91 88 89 20 0.0001
aP < 0.05 in comparison to score 0. bP < 0.05 in comparison to score 1.
considered: <5%, <10%, <15%, or <20%. For this pur-
pose, each of these transformations was analyzed by for-
ward stepwise multivariate regression analysis, including
cv and ci scores, and the best prediction of 3 months’ GFR
was obtained when glomerulosclerosis was cutoff at 10%
(R = 0.66, P < 0.0001).
To ascertain the clinical utility of the simultaneous eval-
uation of all three renal compartments, a chronic damage
score was generated as the addition of glomeruloscle-
rosis categorized as 0 for glomerulosclerosis ≤10% and
1 for glomerulosclerosis > 10%, cv score, and ci score.
GFR at 3 months and death-censored graft survival were
significantly associated with the chronic damage score
(Table 4).
Despite Vvint/c and maximal Vvintima/art were asso-
ciated with death-censored graft survival (RR 1.11 and
95%CI 1.06 to 1.17 and RR 1.04 and 95% CI 1.01 to 1.10,
respectively), multivariate analysis showed that donor
chronic damage score was the only histologic indepen-
dent predictor of death-censored graft survival (RR 3.9
and 95% CI 1.7 to 8.9).
Relationship between clinical data, histologic lesions,
and graft outcome
Donor age (R = 0.57, P < 0.0001) and delayed graft
function were the only clinical variables associated with
3 months’ GFR in the univariate analysis. Twenty patients
suffering from delayed graft function had a 3 months’
GFR of 42 ± 21 mL/min/1.73 m2 while 53 patients with
immediate graft function showed a 3 months’ GFR of
64 ± 20 mL/min/1.73 m2 (P < 0.0001). There was no signif-
icant relationship between 3 months’ GFR and number of
HLA mismatches, cold ischemia time, immunosuppres-
sive therapy, or acute rejection.
A stepwise multivariate regression analysis to predict
3 months’ GFR was done considering donor chronic dam-
age score, donor age, and delayed graft function. As
shown in Table 5, the three variables were entered into
the model.
Univariate Cox regression analysis showed that donor
chronic damage score (RR 2.2 and 95% CI 1.5 to 3.3)
(P < 0.0001), delayed graft function (RR 10 and 95% CI
2.6 to 37) (P < 0.0001), and number of HLA mismatches
(RR 2.1 and 95% CI 1.1 to 4.1) (P = 0.024) were associ-
ated with death-censored graft survival. Multivariate Cox
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Table 5. Independent predictors of 3 months’ glomerular filtration
rate (GFR) estimated according to stepwise multivariate regression
analysis
Variable R R2 P value
Chronic damage score 0.64 0.41
Delayed graft function 0.68 0.47
Donor age 0.71 0.50 0.0001
regression analysis showed that only donor chronic dam-
age score (RR 2.2 and 95% CI 1.3 to 3.7) (P = 0.0024) and
delayed graft function (RR 4.7 and 95% CI 1.0–22) (P =
0.049) were independent predictors of graft survival.
DISCUSSION
The Banff classification has become an international
standard in the evaluation of renal allograft biopsies
[14]. Although this classification has been developed to
evaluate episode biopsies, it has also been applied to
evaluate protocol biopsies. Despite histologic lesions in
protocol biopsies are rather mild, the presence of acute
and chronic lesions evaluated per Banff correlates with
allograft outcome [17–19]. Donor biopsies, usually do
not display acute inflammatory lesions and the range of
chronic lesions is even narrower than in protocol biopsies.
For this reason, some authors have proposed to evaluate
donor biopsies with a very detailed semiquantitative scale
in order to differenciate groups in this range of lesions [8,
20, 21], while others have proposed to employ a mor-
phometric approach [11–13, 22]. However, the possible
utility of the evaluation of donor biopsies according to
Banff criteria has not been properly assessed.
In the current study, we evaluated donor biopsies ac-
cording to Banff criteria and with a morphometric ap-
proach. We observed that the severity of chronic lesions
in each renal compartment correlates with the presence
of delayed graft function, renal function at 3 months, and
death-censored graft survival. These results confirm that
the following parameters are associated with graft out-
come: ci score [7], cv score [8], percentage of glomeru-
losclerosis [10], Vvint/c [11], Vvintima/art [13], and Vg
[12]. This result raises the question about which mea-
surements allow a better prediction of graft outcome.
The histologic variable that better correlated in the
univariate analysis with graft function at 3 months
was Vvint/c. Furthermore, this morphometric parameter
also correlated with death-censored graft survival. Since
Vvint/c and ci score are surrogate measures of interstitial
fibrosis in donor biopsies, we studied whether the mor-
phometric evaluation, which is rather time-consuming,
significantly improved the prediction of graft outcome
adjusting for other histologic and clinical variables.
Two surrogate measures of glomerular damage, the
percentage of glomerulosclerosis and glomerular volume,
were associated with outcome [9, 10, 12]. The percent-
age of glomerulosclerosis, that can be precisely estimated
in frozen or paraffin-embedded sections, has become a
widely employed parameter to evaluate donor biopsies.
However, there is no agreement in the minimum sam-
ple size and the best cutoff for this parameter. We show
that in donor biopsies containing at least ten glomeruli,
which represents the minimum sample size according to
the Banff criteria, the percentage of glomerulosclerosis
is a reasonable predictor of graft outcome. Despite that,
we found that the best cutoff was 10%, different figures
ranging between 10% and 20% have been described [9,
10]. Probably, this variability is related to the different
characteristics of studied populations and/or small sam-
ple size. Furthermore, we confirm that larger glomeruli
in donor biopsy are associated with a poorer outcome
[12]. Glomerular volume is considered a surrogate mea-
sure of glomerular number since there is an inverse re-
lationship between both parameters [23, 24]. It has been
suggested that once glomeruli have been enlarged as an
age-dependent adaptation in the donor kidney, their ca-
pacity to further enlarge after transplantation due to an
additional increase of metabolic demand is already ex-
hausted [25].
Fibrous intimal thickening evaluated either with cv
score or morphometry was associated with 3 months’
GFR and death-censored graft survival as it has been
previously reported [8, 13]. Once more, this observation
raises the question whether the morphometric parameter
is superior to the semiquantitative evaluation
In order to determine whether outcome was bet-
ter predicted by more than one lesion and to evaluate
whether morphometry offers any advantage over semi-
quantitative grading, different multivariate analysis were
performed. In the present study, multivariate analysis re-
vealed that the evaluation of chronic damage in all renal
compartments allows a better accuracy on the predic-
tion of graft outcome than the evaluation of any single
renal compartment. When all histologic variables asso-
ciated with renal function were considered, Vvint/c and
percentage of glomerulosclerosis were independent pre-
dictors of renal function. Since morphometric evaluation
of renal interstitium is rather time-consuming and Vvint/c
correlates with the degree of ci score, we studied the as-
sociation between renal damage and graft function not
considering the morphometric measures. In this second
analysis, the percentage of glomerulosclerosis, cv score,
and ci score were independent predictors of graft func-
tion. Three months’ GFR variability was similarly ex-
plained by both statistical models. This observation has
two important implications. First, despite the theoreti-
cal advantage of a morphometric approach to allow a
more accurate evaluation of chronic renal damage, it does
not offer a clear advantage in the evaluation of preim-
plantation biopsies. Obviously, this observation does not
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exclude that a morphometric approach is superior than
a semiquantitative grading to study sequential renal allo-
graft biopsies [26, 27]. The second implication is that our
results suggest that the consideration of chronic lesions
in the glomerular, vascular, and interstitial compartments
allows a better prediction of 3 months’ GFR than any in-
dividual lesion, supporting that a sum of scores of these
compartments may be the best approach to evaluate pre-
existing chronic damage in donor biopsies. The utility of
donor chronic damage score was further supported by the
observation that this score was the only histologic inde-
pendent predictor of death-censored graft survival, even
when the statistical model was adjusted for clinical vari-
ables. Accordingly, our data support that kidneys with a
chronic damage score ≤ 1 are suitable for transplantation
while kidneys with a score ≥ 3 display a too low graft sur-
vival suggesting that they may be inadequate for single
transplantation. Taking into consideration other clinical
experiences [5, 28], we cannot discard that this last group
of kidneys may be suitable for dual transplantation. Fi-
nally, kidneys with a chronic damage score = 2 have a
similar graft survival than kidneys with a score ≤ 1 but a
poorer graft function at 3 months. This result points out
that they may be used for single transplantation but it will
be desirable to avoid further injuries such as prolonged
cold ischemia, acute rejection, or drug nephrotoxicity.
CONCLUSION
We show that the simultaneous evaluation of donor
glomerulosclerosis, chronic vascular and interstitial dam-
age according to Banff criteria allows a rather precise
prediction of graft outcome. The morphometric evalua-
tion does not offer any advantage in comparison to Banff
criteria.
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